Related Experiment Video
Updated: Aug 11, 2026

12:40
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
Published on: December 7, 2014
The effect of the JAK2 V617F mutation on PRV-1 expression
Haematologica
|March 1, 2006
Summary
The JAK2(V617F) mutation increases polycythemia rubra vera 1 (PRV-1) expression in myeloid cells. A JAK2 inhibitor reversed this effect, highlighting a potential therapeutic target for myeloproliferative disorders.
Area of Science:
- Molecular Biology
- Hematology
- Oncology
Background:
- The Janus kinase 2 (JAK2) V617F mutation is prevalent in polycythemia vera (PV) and other myeloproliferative neoplasms (MPNs).
- Polycythemia rubra vera 1 (PRV-1) is a gene overexpressed in PV, serving as a potential biomarker.
Purpose of the Study:
- To investigate the impact of the JAK2(V617F) mutation on PRV-1 expression.
- To explore the therapeutic potential of JAK2 inhibition in modulating PRV-1 levels in MPNs.
Main Methods:
- Utilized an in vitro model employing murine myeloid cells.
- Compared PRV-1 expression in cells with JAK2(V617F) versus wild-type JAK2.
- Administered a JAK2 inhibitor to assess its effect on PRV-1 levels.
Main Results:
- The presence of JAK2(V617F) significantly elevated both PRV-1 protein and mRNA levels compared to wild-type JAK2.
- Treatment with a JAK2 inhibitor effectively abolished the V617F-induced increase in PRV-1 expression.
Conclusions:
- The JAK2(V617F) mutation directly upregulates PRV-1 expression in myeloid cells.
- JAK2 inhibition demonstrates potential as a therapeutic strategy for managing PRV-1 overexpression in MPNs.
Related Concept Videos
The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
Pleiotropy
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Point and Frameshift Mutations
Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...

